Media headlines about St Jude Medical (NYSE:STJ) have trended positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. St Jude Medical earned a media sentiment score of 0.32 on Accern’s scale. Accern also assigned media coverage about the medical technology company an impact score of 47.1961459464198 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.31 and a current ratio of 1.93.
COPYRIGHT VIOLATION NOTICE: “St Jude Medical (STJ) Earning Positive Media Coverage, Report Shows” was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.com-unik.info/2018/01/30/st-jude-medical-stj-earning-positive-media-coverage-report-shows.html.
About St Jude Medical
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.